Breaking News, Promotions & Moves

Univercells Technologies Names CEO

Mathias Garny to lead the growth and commercialization strategy for biomanufacturing product portfolio and new technology developments.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Univercells S.A. and Gamma Biosciences have appointed Mathias Garny as the Chief Executive Officer of Univercells Technologies, a global provider of next-gen bioprocess technologies. The appointment comes as the company focuses on commercializing its product portfolio and new technology developments to further expand market reach.   Acting as General Manager, Mr. Garny has been responsible for overseeing the Company’s operations and leading the strategy development and implementation. Under hi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters